Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
* Reuters is not responsible for the content in this press release.
Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo
LLC
CHAPEL-EN-LE-FRITH, England and MILPITAS, California, August 27
/PRNewswire/ -- Peakdale Molecular Ltd (CHAPEL-EN-LE-FRITH, UK) a leading
provider in specialist chemistry services to the pharmaceutical and
biotechnology industry, and ChemPrintCo LLC (MILPITAS, CA, USA), a unique and
cost-effective provider of products and systems for the biotechnology
industry, today announce the launch of AssayReady4U(TM).
AssayReady4U(TM) is an online based storefront which allows drug
discovery researchers the ability to search, design and select compounds from
a live physical collection of screening compounds. Then, using additional
options, build their final assay by selecting the exact amount and
concentration required to perform their own unique experiments.
The final customer-selected compounds are cleanly and accurately
dispensed into SBS standard well plates of the customer's choosing using
ChemPrintCo's sophisticated and proprietary hydro-acoustic technologies. Each
AssayReady4U plate is sealed in an argon environment and then vacuum-sealed
in a moisture barrier bag and placed inside a temperature-controlled pack for
shipment. All orders are shipped from stock within 24 hours of completion
using a commercial carrier. Upon receipt, the customer adds an appropriate
amount of solvent to reach the desired test concentration.
Peakdale's collection is fundamentally rich in novel, GPCR-targeted
compounds. All compounds in the collection are selected for their
applicability to GPCR research. Well-recognized ligand features are combined
with proprietary scaffolds and monomers to produce a set of screening
compounds for GPCR hit discovery.
Glenn Killingworth, Director of Business Development at Peakdale said: "I
am excited that we have built this collaboration in order to reach the
smaller drug-research groups who don't want to build assets to store, handle
and plate compounds, but just want to receive ready-to-screen assays from a
high quality collection, in exactly the format that they need to perform
their drug discovery work."
Peakdale's Director of Technology Paul Doyle said: "This represents an
exciting new technology that allows a much broader base of researchers to
access the world of diverse compounds in a cost effective manner."
Adding to this, ChemPrintCo's Vice President of Sales Ron Jones said:
"The AssayReady4U(TM) products will be offered via an innovative web-based
one-stop shopping storefront. The researchers will effortlessly select
compounds, assay test concentration, plate format, plate manufacturer and
controls with a few clicks of a mouse thus optimizing their valuable time for
research."
About Peakdale Molecular
Peakdale Molecular was founded in 1992. Today the company's customers
include the majority of the major global pharmaceutical businesses and a
rapidly growing base of biotechnology companies worldwide. Peakdale's teams
of chemists combine experience in pharmaceutical R&D, medicinal chemistry,
parallel synthesis, process development and fine chemicals to deliver unique
chemistry solutions to a range of drug discovery challenges. Peakdale has
growing capabilities in computational chemistry, analytical chemistry and
ADME screening.
The application of less commonly used chemistry, including high
temperature/pressure reactions, proprietary heterocyclic chemistry and
nucleoside synthesis, enables Peakdale's chemists to generate unique
compounds for drug discovery. Peakdale operates in several distinct markets
providing novel screening compounds, targeted screening libraries, catalogue
intermediates, custom synthesis and contract research. Further information
about the company can be obtained at http://www.peakdale.com
About ChemPrintCo LLC
ChemPrintCo is a privately held company located in the heart of Silicon
Valley and the Bay Area's deep biotech and pharmaceutical community. The
management team has been together for over 15 years developing unique and
cost-effective products and systems for the biotech and high-technology
industries. Their mission is to address the needs of the individual
scientific researcher with ready-to-use assays in a single-use well plate
format. We accomplish this by giving each researcher the ability to select
compounds from leading suppliers in the exact amount and concentration
required to perform their own unique experiments.
For more information please contact
Peakdale Molecular Ltd ChemPrintCo LLC
Glenn Killingworth Roger Williams
Director of Business Development President
Peakdale Molecular Ltd ChemPrintCo. LLC
Peakdale Science Park 1804 McCarthy Boulevard
Sheffield Road Milpitas
Chapel-en-le-Frith California
High Peak 95035
UK USA
Tel +44(0)1298-816700 Tel +1-408-273-2300
Fax +44(0)1298-816701
http://www.peakdale.com/AssayReady4U.htm
http://chemprintco.googlepages.com/home
SOURCE Peakdale Molecular Ltd and ChemPrintCo LLC
For more information please contact: Peakdale Molecular Ltd, Glenn
Killingworth, Director of Business Development, Peakdale Molecular Ltd,
Peakdale Science Park, Sheffield Road, Chapel-en-le-Frith, High Peak, UK, Tel
+44(0)1298-816700, Fax +44(0)1298-816701; ChemPrintCo LLC, Roger Williams,
President, ChemPrintCo. LLC, 1804 McCarthy Boulevard, Milpitas, California,
95035, USA, Tel +1-408-273-2300
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters